Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 6 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kansas AG sues Pfizer over 'misleading' COVID-19 vaccine claims
FOX 23 Maine· 7 days agoKansas Attorney General Kris Kobach announced Monday he is suing pharmaceutical giant Pfizer for...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 5 days agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine ...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 6 days agoCiting the 69-page lawsuit submitted to the District Court of Thomas County, Fox Business highlights that Pfizer misled the public by claiming its COVID ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 5 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in...
Biden admin seeks to delay releasing data on COVID vaccine reactions, report says
NBC Montana· 4 days agoThe Biden administration on Tuesday asked for a delay in releasing data on reactions to COVID-19 ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 4 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. ...